XENETIC BIOSCIENCES, INC. Adjustment of Warrants Granted for Services
XENETIC BIOSCIENCES, INC. (XBIO) reported Adjustment of Warrants Granted for Services of -$26.58 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2019-05-13
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for the quarter ending 2019-03-31 was -$26.58K, a 640.49% decline year-over-year.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for the quarter ending 2018-12-31 was -$14.73K.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for the quarter ending 2018-09-30 was -$38.79K.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for the quarter ending 2018-06-30 was $58.82K.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for fiscal 2018 was $10.21K.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for fiscal 2017 was -$126.32K, a 111.26% decline from fiscal 2016.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for fiscal 2016 was $1.12M, a 20.17% increase from fiscal 2015.
- XENETIC BIOSCIENCES, INC. adjustment of warrants granted for services for fiscal 2015 was $933.20K.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$26.58K 10-Q · filed 2019-05-13 | -$41.31K derived: sum of 2 quarters · filed 2019-05-13 | -$80.10K derived: sum of 3 quarters · filed 2019-05-13 | -$21.29K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-12-31 | -$14.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$53.53K derived: sum of 2 quarters · filed 2019-03-29 | $5.29K derived: sum of 3 quarters · filed 2019-03-29 | $10.21K 10-K · filed 2019-03-29 |
| 2018-09-30 | -$38.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $20.02K derived: sum of 2 quarters · filed 2018-11-09 | $24.94K 10-Q · filed 2018-11-09 | $16.86K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-06-30 | $58.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $63.73K 10-Q · filed 2018-08-10 | $55.65K derived: sum of 3 quarters · filed 2019-05-13 | $33.32K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-03-31 | $4.92K 10-Q · filed 2019-05-13 | -$3.16K derived: sum of 2 quarters · filed 2019-05-13 | -$25.49K derived: sum of 3 quarters · filed 2019-05-13 | -$106.05K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$8.08K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$30.41K derived: sum of 2 quarters · filed 2019-03-29 | -$110.97K derived: sum of 3 quarters · filed 2019-03-29 | -$126.32K 10-K · filed 2019-03-29 |
| 2017-09-30 | -$22.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$102.89K derived: sum of 2 quarters · filed 2018-11-09 | -$118.24K 10-Q · filed 2018-11-09 | -$113.62K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$80.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$95.91K 10-Q · filed 2018-08-10 | -$91.29K derived: sum of 3 quarters · filed 2018-08-10 | |
| 2017-03-31 | -$15.35K 10-Q · filed 2018-05-15 | -$10.73K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $4.61K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $1.12M 10-K · filed 2018-03-30 | ||
| 2016-09-30 | $1.12M 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $933.20K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |